• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自羊膜-绒毛膜的半胱氨酸蛋白酶促凝剂。

Cysteine proteinase procoagulant from amnion-chorion.

作者信息

Gordon S G, Hasiba U, Cross B A, Poole M A, Falanga A

出版信息

Blood. 1985 Dec;66(6):1261-5.

PMID:3933592
Abstract

Various coagulation abnormalities are associated with pregnancy. Several investigators have suggested that there may be a unique procoagulant associated with amniotic tissue and fluid. We identified a cysteine proteinase from malignant tissue, cancer procoagulant, and had reason to believe a similar proteinase may be present in amniotic tissue. Amniotic fluid and extracts of amnion-chorion were purified by immunoaffinity chromatography with an antibody that was developed to cancer procoagulant antigen. The purified amnion-chorion procoagulant initiated clotting in normal and factor VII-deficient citrated human plasma and directly activated pure human factor X in a two-stage clotting assay. It was inhibited by 1 mmol/L of iodoacetamide and 0.1 mmol/L of HgCl2, and the procoagulant activity was activated by 10 mmol/L of KCN; these are classic properties of cysteine proteinases. The pure amnion-chorion procoagulant had the same mol wt and immunologic determinants as cancer procoagulant from rabbit V2 carcinoma, as determined by crossed immunodiffusion, suggesting that the same or very similar proteins were associated with both tissues. Thus, this procoagulant may be derived from both undifferentiated and dedifferentiated cells.

摘要

多种凝血异常与妊娠相关。一些研究者认为,可能存在一种与羊膜组织和羊水相关的独特促凝剂。我们从恶性组织中鉴定出一种半胱氨酸蛋白酶——癌促凝剂,并有理由相信羊膜组织中可能存在类似的蛋白酶。用针对癌促凝剂抗原制备的抗体,通过免疫亲和层析法对羊水和羊膜 - 绒毛膜提取物进行纯化。纯化后的羊膜 - 绒毛膜促凝剂可在正常和缺乏因子VII的枸橼酸化人血浆中引发凝血,并在两阶段凝血试验中直接激活纯人因子X。它受到1 mmol/L碘乙酰胺和0.1 mmol/L HgCl2的抑制,其促凝活性被10 mmol/L KCN激活;这些是半胱氨酸蛋白酶的典型特性。通过交叉免疫扩散测定,纯化后的羊膜 - 绒毛膜促凝剂与兔V2癌的癌促凝剂具有相同的分子量和免疫决定簇,这表明两种组织中存在相同或非常相似的蛋白质。因此,这种促凝剂可能来源于未分化和去分化细胞。

相似文献

1
Cysteine proteinase procoagulant from amnion-chorion.来自羊膜-绒毛膜的半胱氨酸蛋白酶促凝剂。
Blood. 1985 Dec;66(6):1261-5.
2
Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.癌促凝物质的分离与特性:一种来自恶性组织的半胱氨酸蛋白酶。
Biochemistry. 1985 Sep 24;24(20):5558-67. doi: 10.1021/bi00341a041.
3
A factor X-activating cysteine protease from malignant tissue.一种来自恶性组织的X因子激活半胱氨酸蛋白酶。
J Clin Invest. 1981 Jun;67(6):1665-71. doi: 10.1172/jci110203.
4
Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant.癌促凝素与人类羊膜绒毛促凝素特性的比较。
Biochim Biophys Acta. 1985 Sep 20;831(1):161-5. doi: 10.1016/0167-4838(85)90165-7.
5
Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues.直接分析显示,人体组织中癌促凝物质不存在γ-羧基谷氨酸。
Blood Coagul Fibrinolysis. 2009 Jul;20(5):315-20. doi: 10.1097/MBC.0b013e32831bc2c5.
6
Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.几种具有转移特性的小鼠肿瘤都有一种具有癌促凝特性的半胱氨酸蛋白酶。
Int J Cancer. 1987 Jun 15;39(6):774-7. doi: 10.1002/ijc.2910390620.
7
A proteolytic procoagulant associated with malignant transformation.一种与恶性转化相关的蛋白水解促凝剂。
J Histochem Cytochem. 1981 Mar;29(3A Suppl):457-63. doi: 10.1177/29.3.457.
8
The site of activation of factor X by cancer procoagulant.癌促凝物激活因子X的位点。
Blood Coagul Fibrinolysis. 1991 Dec;2(6):735-9. doi: 10.1097/00001721-199112000-00007.
9
A new procoagulant in acute leukemia.急性白血病中的一种新型促凝剂。
Blood. 1988 Apr;71(4):870-5.
10
Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent.胃癌、结直肠癌和肾癌的促凝血活性依赖于凝血因子VII。
J Cancer Res Clin Oncol. 1988;114(5):519-22. doi: 10.1007/BF00391504.

引用本文的文献

1
Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in Patients With Solid Cancer.肿瘤基因组特征与实体癌患者的动脉血栓栓塞风险相关。
JACC CardioOncol. 2023 Apr 18;5(2):246-255. doi: 10.1016/j.jaccao.2023.01.009. eCollection 2023 Apr.
2
Procoagulant extracellular vesicles in amniotic fluid.羊水中的促凝血细胞外囊泡。
Transl Res. 2017 Jun;184:12-20.e1. doi: 10.1016/j.trsl.2017.01.003. Epub 2017 Feb 4.
3
The hypercoagulable state of malignancy: pathogenesis and current debate.恶性肿瘤的高凝状态:发病机制与当前争论
Neoplasia. 2002 Nov-Dec;4(6):465-73. doi: 10.1038/sj.neo.7900263.
4
Pathogenesis of thrombosis in patients with malignancy.恶性肿瘤患者血栓形成的发病机制。
Int J Hematol. 2001 Feb;73(2):137-44. doi: 10.1007/BF02981929.
5
Disseminated intravascular coagulation: diagnosis and treatment.弥散性血管内凝血:诊断与治疗
BMJ. 1996 Mar 16;312(7032):683-7. doi: 10.1136/bmj.312.7032.683.
6
Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase.骨组织的胶原olytic半胱氨酸蛋白酶。组织蛋白酶B、(前)组织蛋白酶L和一种70 kDa的组织蛋白酶L样蛋白酶。
Biochem J. 1991 Oct 1;279 ( Pt 1)(Pt 1):167-74. doi: 10.1042/bj2790167.
7
Non-tissue factor procoagulants in cancer cells.癌细胞中的非组织因子促凝剂。
Cancer Metastasis Rev. 1992 Nov;11(3-4):267-82. doi: 10.1007/BF01307182.
8
Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients.肺癌患者中的因子IXi-抗凝血酶(IXiAT)和凝血酶-抗凝血酶(TAT)复合物。
Ann Hematol. 1992 Jan;64(1):35-9. doi: 10.1007/BF01811469.